FDA Inspection
DOW LAO Blood BankDOW LAO Blood Bank – FDA Inspection, Jun 28, 2018
Record Details
This FDA Inspection record concerns DOW LAO Blood Bank, with an inspection on June 28, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 3c470ece-5fd9-4027-9c48-35187d097539
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1062223
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of DOW LAO Blood Bank
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 12, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 7, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 25, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 14, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 23, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for DOW LAO Blood Bank
- FDA Inspection 1211182 - 2023-07-12
- FDA Inspection 967541 - 2016-04-07
- FDA Inspection 871324 - 2014-03-25
- FDA Inspection 786396 - 2012-06-14
- FDA Inspection 681928 - 2010-09-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.